Asahi Kasei Bioprocess to Unveil THESYS™ ACS ERGO Synthesis Column at TIDES USA

Offering reduced changeover time while maintaining safety and product quality TOKYO & NEW YORK & DÜSSELDORF, Germany ---Generating cutting-edge therapeutics requires precision, safety, and efficiency from manufacturing equipment. The next generation of oligo manufacturing, the process of producing short sequences of nucleotides (building blocks of DNA or RNA), innovation from Asahi Kasei Bioprocess (AKB), the THESYS™ ACS ERGO [...]

Parse Biosciences Launches Single Cell Immune Profiling Products

New single cell BCR and TCR profiling products enable immune profiling at unprecedented scale SEATTLE – Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, today announced the availability of Evercode™ BCR and the expansion of its existing Evercode™ TCR product line. The new BCR solution and updates to the existing TCR [...]

Charles River Launches Viral Vector Reference Materials to Streamline the Transition to GMP

Supporting scale-up for early-phase AAV- and LVV-based gene and gene-modified cell therapy researchers and developers WILMINGTON, Mass. -- Charles River Laboratories International, Inc. (NYSE: CRL) today announced the launch of its reference materials for adeno associated virus (AAV) and lentiviral vector (LVV) portfolio, designed to streamline Cell and Gene Therapy (CGT) research and development as [...]

QIAGEN enhances bioinformatics workflows with new secondary analysis solution for oncology and inherited disease applications

QCI Secondary Analysis a cloud-based software directly integrated with QCI Interpret, enabling high-throughput secondary analysis of clinical next-generation sequencing data New software advances precision medicine by enabling smaller and decentralized labs to adopt NGS testing with efficiency, consistency and confidence Combination of QCI Secondary Analysis and QCI Interpret provide a secure and compliant environment for [...]

Ultima Genomics Adds Former Thermo Fisher Exec Mark Stevenson to Board of Directors

Mark Stevenson, with more than 30 years of experience in the life sciences sector, formerly Executive Vice President and Chief Operating Officer of Thermo Fisher Scientific joins Ultima Genomics’ Board of Directors FREMONT, Calif. --  Ultima Genomics, a developer of an innovative new ultra-high throughput sequencing architecture, today announced that Mark Stevenson will join its [...]

Gyros Protein Technologies introduces Gyrolab Generic Rodent ADA Kit Reagents to support preclinical immunogenicity assessment

Ready-to-use kit expands range of bioanalysis kits, and enables generic detection of immune complexes in rodent samples Uppsala, Sweden: Gyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and a leading provider of peptide synthesizers and reagents, today announced the introduction of Gyrolab® Generic Rodent Anti-Drug Antibody (ADA) Kit Reagents for the detection of circulating immune [...]

Akoya Biosciences and Shanghai KR Pharmtech Announce Chinese Regulatory Agency Premarket Approval for KR-HT5 in China to Support Next Generation Pathology Clinical Workflows

KR-HT5 is based on Akoya’s PhenoImager® HT Platform MARLBOROUGH, Mass. and SHANGHAI, China -- Akoya Biosciences, Inc. (Nasdaq: AKYA), The Spatial Biology Company®, and Shanghai KR Pharmtech, a leading company providing molecular diagnostic solutions in China, have jointly announced that KR-HT5, which Akoya Biosciences co-developed with Shanghai KR Pharmtech utilizing the PhenoImager HT technology as [...]

Nuclera eProtein Discovery system installed at leading academic institutes

11 installs successfully completed Novel platform automates and accelerates protein production, enabling scale-up to mg amount in less than 48 hours List of institutes includes, University College London, University of Cambridge, University of Southampton, University of Manchester, The Flanders Institute for Biotechnology (VIB) in Belgium, and the CRUK Cambridge Institute Cambridge, UK: Nuclera, the biotechnology company [...]

Bruker Completes Acquisition of Molecular Diagnostics Innovator ELITech

ELITech is a differentiated, fast growing and profitable provider of systems and assays for molecular diagnostics (MDx), biomedical systems/specialty IVD, and microbiology ELITech offers the proprietary, fully automated sample-to-answer (S2A) systems InGenius® and BeGenius® for molecular testing in mid-sized hospitals Diversified ELITech MDx assay portfolio focused on esoteric infectious disease testing ELITech has its R&D, [...]

CellChorus Awarded $2.5 million SBIR Fast-Track Grant by the National Center for Advancing Translational Sciences

Up to $2.5 million in funding from NIH will be used to develop TIMING™ kits for manufacturing analytics that provide end-users with rapid, specific and predictive results to accelerate translational research and the development and manufacture of more effective cell therapies to benefit patients PRESS RELEASE HOUSTON, Texas — CellChorus®, the dynamic single-cell analysis company™, [...]

Access IBO on Knowledge Center